Positive Expiratory Pressure (PEP) and Continuous High-frequency Oscillation (CHFO) on Lung RECRUITment Using Electrical Impedance Tomography (EIT) - The PEP-RECRUIT Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Genova

About this trial

This single-center observational study aims to assess the effects of continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP) therapy on lung recruitment using electrical impedance tomography (EIT) in spontaneously breathing patients admitted to the intensive care unit.

Eligibility criteria

Qualifiers

Patients who require pulmonary expansion and airway clearing as per clinical indication

Patients who provide valid informed consent according to local regulations

PaO2/FiO2 < 200 mmHg at inclusion

Patient on the Airway Care Score (ACS) < 7

Disqualifiers

Refuse to participate

Age < 18 years

Hemodynamic instability, defined as systolic arterial pressure < 90 mmHg or mean pressure < 60 mmHg

Contraindication to using an EIT (i.e., pacemaker or defibrillator)

Trial design

Treatments tested in this trial

  • Continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP) therapy

Treatment groups

No treatment groups listed

Sponsors and collaborators

University of Genova

Lead sponsor

Denise Battaglini

Collaborator